HIV prevention study starts in Southern Africa
A South African based NGO – International Partnership for Microbicides (IPM) – is leading a study to test whether a microbicide vaginal ring which slowly releases the ARV drug dapivirine can prevent HIV infection.
The ring study, which has just started in South Africa, will see the technology tested on more than 1 600 women in SA, Malawi and Rwanda.
The ring, which is designed to stay in a woman’s body for a month, will be tested on women between the ages of 18 and 45.
“The ring study presents an important technological advancement. The ring might provide protection not only because of the active drug, but also because women only need to put the ring in once a month so it stays in the body and could offer protection throughout this time,” Dr Zeda Rosenberg, CEO at IPM said.
Rosenberg said of the 1 650 participants, 1 110 would be on the ring that contained dapivirine while 550 would be in the placebo group.
The study is expected to be completed in 2015.
Shortlink:
Posted by You Might Also Like:
Vivian Chizoba Ajoku, Africasti Abuja. A Major new research is beginning in five African countries to see whether a special ...
Attempting to prevent HIV infection via vaginal gels or daily medicine has proven to be ineffective in the southern African re ...
Now that three studies have shown that circumcising adult heterosexual men is one of the most effective “vaccines” against Aid ...
Rwanda has concluded plans to circumcise 50 per cent of its men between now and 2013 as part of a national effort to reduce th ...
The celebrated South African tenofovir vaginal gel acknowledged for preventing the transmission of HIV in women after trials i ...
Recent Comments